Personalis, Inc. (PSNL): Shareholders' Equity
$261.19M
As of 2025-12-31
$235.16M
As of 2026-06-30
+6.2%
3-year compound annual growth
+6.0%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $261.19M | +28.7% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $202.96M | +56.8% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $129.44M | -40.7% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $218.14M | -29.7% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $310.30M | +59.2% | 2024-02-28, Balance as of period end |
| 2020-12-31 | $194.94M | +82.7% | 2023-02-23, Balance as of period end |
| 2019-12-31 | $106.69M | n/m | 2022-02-24, Balance as of period end |
| 2018-12-31 | -$106.39M | n/m | 2021-02-25, Balance as of period end |
| 2017-12-31 | -$92.60M | n/a | 2020-03-25, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Personalis, Inc. (PSNL) | 2025-12-31 | $261.19M | +28.7% |
| Exagen Inc. (XGN) | 2025-12-31 | $17.45M | +82.9% |
| Biodesix Inc (BDSX) | 2025-12-31 | -$2.46M | n/m |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $2.58B | +3.0% |
| CapForce Inc. (CFOR) | 2025-12-31 | $31.86M | +331.6% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $27.69M | -7.8% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $480.11M | n/m |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $1.11B | -1.9% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $470.87M | +3.3% |
Compare PSNL, XGN, BDSX, GRAL side by side · Screen every company in Services-Medical Laboratories ↗